Skip to main content
. 2023 Dec 20;23(1):161–174. doi: 10.1021/acs.jproteome.3c00513

Figure 5.

Figure 5

Overview of the developmental process of the platform was created for rapid serotype identification and PTM monitoring. Serotypes are analyzed using HILIC-MS instrumentation controlled by Chromeleon. Components are identified using BioPharma Finder where component workbooks are generated. These workbooks are imported back into Chromeleon where methods for rapid serotype identification and specific serotype PTM monitoring were created and tested. Methods can then be used for release testing and quality control where results can easily be generated within the software.